Verano Holdings (VRNO) Divestments (2021 - 2025)

Verano Holdings (VRNO) posted quarterly Divestments of $9.1 million for Q1 2025, up 3528.4% quarter-over-quarter from $250000.0 in Q3 2022.

Verano Holdings (VRNO) Divestments (2021 - 2025) Analysis & Trends

Verano Holdings (VRNO) has reported Divestments for 3 consecutive years, with $9.1 million the latest figure, recorded in Q1 2025.

In Q1 2025, Divestments changed N/A year-over-year to $9.1 million; the TTM figure through Dec 2025 stood at $9.1 million (changed N/A YoY), while the FY2025 annual figure was $9.1 million, changed N/A from the prior year.
Divestments rose to $9.1 million in Q1 2025 per VRNO's latest filing, from $250000.0 in the prior quarter.
Across five years, Divestments topped out at $19.8 million in Q1 2022 and bottomed at -$10.3 million in Q4 2021.
Historically, Divestments has averaged $3.7 million across 3 years, with a median of $250000.0 in 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	4.00 Mn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	65.64 Mn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Verano Holdings	433.71 Mn	348.51 Mn	99.70 Mn	-

Download Data